Lung function tests are required to assess the basic function of the lungs. PFTs, which comprise lung volumes, lung capacities, rates of flow, and gas exchange, provide clinicians with information that aids in the diagnosis of many lung illnesses, particularly COPD. Technological advances are projected to have a significant impact on the market. The main Spirometer Market participants' large investments in extended research and development of novel and sophisticated diagnostic and monitoring technologies are projected to enable early diagnosis of COPD.

The development of portable, hand-held, and user-friendly spirometry equipment has helped to overcome the underutilization of pulmonary function testing. For example, NuvoAir's linked spirometer was approved for sale in the United States by the Food and Drug Administration in January 2020. The gadget is intended for use with conditions such as COPD, asthma, and cystic fibrosis. As a result, ongoing innovation is one of the main factors driving the Spirometer Market.

Read the Complete Report- https://cmi-latestreportorientedblogs.blogspot.com/2023/04/the-rising-prevalence-of-copd-to-boost.html